Can the measles‑mumps‑rubella (MMR) vaccine be administered three weeks after a varicella (chickenpox) vaccine in a healthy child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MMR Administration 3 Weeks After Varicella Vaccine

No, you cannot give MMR vaccine 3 weeks after varicella vaccination—you must wait at least 4 weeks (28 days) between these live vaccines when they are not administered simultaneously. 1, 2

Minimum Interval Requirements for Live Vaccines

The absolute minimum interval between MMR and varicella vaccines when not given on the same day is 28 days (4 weeks). 1, 2 This requirement applies universally to all age groups and is mandated by both ACIP guidelines and FDA labeling. 1

  • Live-attenuated virus vaccines that are not administered simultaneously must be spaced by at least one month to avoid viral interference. 1
  • If the interval between two live vaccines is less than 28 days, the dose given too early is considered invalid and must be repeated. 1
  • The repeat dose must be administered at least 28 days after the prior valid dose; the remainder of the series does not need to be restarted. 1

Why 3 Weeks Is Insufficient

A 3-week (21-day) interval is unacceptable and requires revaccination. 1 The biological rationale is that live virus vaccines can cause temporary immune interference if given too close together, potentially reducing the immunogenicity of the second vaccine. 1

Correct Vaccination Options

You have two acceptable approaches:

Option 1: Same-Day Administration (Preferred)

  • MMR and varicella vaccines may be administered on the same day at different injection sites. 1, 3, 2
  • Immunogenicity after same-day administration is equivalent to that observed when vaccines are given 4 weeks apart. 1, 4
  • This approach eliminates timing concerns and improves vaccination compliance. 1

Option 2: Sequential Administration

  • If not given simultaneously, wait a minimum of 28 days (4 weeks) between varicella and MMR vaccines. 1, 2
  • For children aged 12 months to 12 years, the minimum interval between varicella doses is 3 months, but when MMR is involved, the 28-day rule for live vaccines takes precedence. 5

Age-Specific Dosing Schedules

Children 12 Months to 12 Years

  • First dose of varicella vaccine: 12-15 months 5
  • Second dose of varicella vaccine: 4-6 years (but may be given earlier if at least 3 months after the first dose) 5
  • MMR doses follow the same schedule: 12-15 months and 4-6 years 6, 5
  • When both vaccines are due, simultaneous administration is strongly recommended. 7, 8

Persons Aged ≥13 Years

  • Both MMR and varicella require two doses with a minimum 4-week interval between doses. 5, 1

Clinical Implications of the 3-Week Scenario

If MMR was inadvertently given 3 weeks after varicella:

  • The MMR dose is considered invalid. 1
  • Repeat the MMR dose at least 28 days after the invalid dose. 1
  • Document the error and ensure proper timing for the repeat dose. 1

Common Pitfalls to Avoid

  • Do not assume that "close enough" intervals are acceptable—the 28-day minimum is absolute for live vaccines. 1
  • Accurate documentation of vaccination dates is essential to prevent inadvertent early administration. 1
  • When scheduling separate visits for live vaccines, always calculate the exact 28-day interval rather than estimating weeks. 1

Combination MMRV Vaccine Considerations

  • The combination MMRV vaccine (ProQuad) is approved for children 12 months to 12 years and provides all four antigens in a single injection. 7, 8
  • For the first dose at ages 12-47 months, either separate MMR and varicella vaccines or MMRV may be used, though separate injections are preferred due to a slightly increased risk of febrile seizures with MMRV in this age group (1 additional febrile seizure per 2,300-2,600 children). 7, 8
  • For the second dose at any age (15 months-12 years) and for the first dose at age ≥48 months, MMRV is generally preferred over separate injections. 7, 8

Related Questions

Can the patient receive the varicella vaccine now, given that they received the measles‑mumps‑rubella (MMR) vaccine on [date] and at least 28 days have passed with no contraindications to live vaccines?
What is the appropriate injection site and route of administration for the measles‑mumps‑rubella‑varicella (MMRV) vaccine?
How should I administer the measles‑mumps‑rubella‑varicella (MMRV) vaccine for catch‑up immunization in a 5‑year‑old child?
Is it safe to give ProQuad (combined measles‑mumps‑rubella‑varicella vaccine) to a 4‑year‑old unimmunized female?
Can the measles‑mumps‑rubella (MMR) vaccine be administered the day after receiving the varicella (chicken‑pox) vaccine?
What evaluation and management steps are recommended for flu-like symptoms that develop after a pembrolizumab (Keytruda) infusion?
How should low folate be managed in a girl receiving high‑dose prednisone?
How should low serum sodium (hyponatremia) on a comprehensive metabolic panel with the remaining values within normal limits be evaluated and managed?
How should a 5 mm solid nodule in the left lower lobe be managed according to Fleischner Society guidelines, taking the patient’s risk factors into account?
What are the recommended oral acyclovir dosing regimens for adult herpes simplex infections (primary genital herpes, recurrent genital herpes, oral labial herpes) and for shingles, and how should the dose be adjusted in immunocompromised patients or those with impaired renal function?
Can a patient on lisinopril 2.5 mg daily, insulin glargine (Lantus), hydroxyzine 25 mg, trazodone 50 mg, risperidone solution, insulin lispro, and nystatin powder safely take Claritin‑D (loratadine/pseudoephedrine)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.